Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer design

被引:15
作者
Boltz, Valerie F. [2 ]
Maldarelli, Frank [2 ]
Martinson, Neil [3 ,5 ]
Morris, Lynn [4 ]
McIntyre, James A. [3 ]
Gray, Glenda [3 ]
Hopley, Mark J. [6 ]
Kimura, Toshio [6 ]
Mayers, Douglas L. [7 ,8 ]
Robinson, Patrick [7 ]
Mellors, John W. [9 ]
Coffin, John M. [2 ,10 ]
Palmer, Sarah E. [1 ,2 ]
机构
[1] Karolinska Inst, Dept Virol, Swedish Inst Infect Dis & Control, S-17182 Solna, Sweden
[2] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21701 USA
[3] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa
[4] Natl Inst Communicable Dis, Johannesburg, South Africa
[5] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[6] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[7] Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA
[8] Idenix Pharmaceut, Cambridge, MA USA
[9] Univ Pittsburgh, Pittsburgh, PA USA
[10] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA
基金
瑞典研究理事会;
关键词
HIV-1; Allele-specific PCR; Low frequency variants; Subtype consensus sequence; Patient-specific HIV-1 consensus sequence; IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITORS; SINGLE-DOSE NEVIRAPINE; RESISTANT HIV-1; ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; TRANSMISSION; POPULATIONS; PERSISTENCE; MUTATIONS;
D O I
10.1016/j.jviromet.2009.11.025
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Allele-specific PCR based on subtype consensus sequences is a powerful technique for detecting low frequency drug resistant mutants in HIV-1 infected patients. However, this approach can be limited by genetic variation in the region complementary to the primers, leading to variability in allele detection. The goals of this study were to quantify this effect and then to improve assay performance. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 19 条
  • [1] Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for Antiretroviral therapy
    Ambrose, Zandrea
    Palmer, Sarah
    Boltz, Valerie F.
    Kearney, Mary
    Larsen, Kay
    Polacino, Patricia
    Flanary, Leon
    Oswald, Kelli
    Piatak, Michael, Jr.
    Smedley, Jerem
    Shao, Wei
    Bischofberger, Norbert
    Maldarelli, Frank
    Kimata, Jason T.
    Mellors, John W.
    Hu, Shiu-Lok
    Coffin, John M.
    Lifson, Jeffrey D.
    KewalRamani, Vineet N.
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (22) : 12145 - 12155
  • [2] Cha R S, 1992, PCR Methods Appl, V2, P14
  • [3] HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY
    COFFIN, JM
    [J]. SCIENCE, 1995, 267 (5197) : 483 - 489
  • [4] HIV RESISTANCE TO REVERSE-TRANSCRIPTASE INHIBITORS
    DECLERCQ, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (02) : 155 - 169
  • [5] Nonnucleoside reverse transcriptase inhibitor resistance
    Deeks, SG
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 : S25 - S33
  • [6] HALVAS EK, 2009, J INFECT DIS
  • [7] Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency
    Halvas, Elias K.
    Aldrovandi, Grace M.
    Balfe, Peter
    Beck, Ingrid A.
    Boltz, Valerie F.
    Coffin, John M.
    Frenkel, Lisa M.
    Hazelwood, J. Darren
    Johnson, Victoria A.
    Kearney, Mary
    Kovacs, Andrea
    Kuritzkes, Daniel R.
    Metzner, Karin J.
    Nissley, Dwight V.
    Nowicki, Marek
    Palmer, Sarah
    Ziermann, Rainer
    Zhao, Richard Y.
    Jennings, Cheryl L.
    Bremer, James
    Brambilla, Don
    Mellors, John W.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (07) : 2612 - 2614
  • [8] Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy
    Hance, AJ
    Lemiale, V
    Izopet, J
    Lecossier, D
    Joly, V
    Massip, P
    Mammano, F
    Descamps, D
    Brun-Vézinet, F
    Clavel, F
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (14) : 6410 - 6417
  • [9] Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors
    Harrigan, PR
    Mo, T
    Wynhoven, B
    Hirsch, J
    Brumme, Z
    McKenna, P
    Pattery, T
    Vingerhoets, J
    Bacheler, LT
    [J]. AIDS, 2005, 19 (06) : 549 - 554
  • [10] Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated
    Johnson, JA
    Li, JF
    Morris, L
    Martinson, N
    Gray, G
    McIntyre, J
    Heneine, W
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (01) : 16 - 23